Latest News about REGN
Recent news which mentions REGN
4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
February 06, 2024
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $6,400 Today
February 06, 2024
From Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
February 06, 2024
Tickers
REGN
From Benzinga
Stock-Split Watch: Could These 2 Market-Beaters Be Next?
February 06, 2024
From Motley Fool
From Benzinga
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
From Benzinga
Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year
February 02, 2024
From Benzinga
Earnings Scheduled For February 2, 2024
February 02, 2024
From Benzinga
3 Top Pharma Stocks to Buy Now: February 2024
February 01, 2024
From InvestorPlace
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
January 29, 2024
From Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
From Benzinga
3 Magnificent Stocks to Buy and Hold Forever
January 27, 2024
From Motley Fool
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
From Benzinga
Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts
January 24, 2024
From Benzinga
3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024
January 23, 2024
From InvestorPlace
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
From Benzinga
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
January 18, 2024
From Benzinga
From InvestorPlace
Regeneron Pharma's Pipeline Makes This Analyst Turn Bullish
January 12, 2024
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
From Benzinga
2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More)
January 04, 2024
From Motley Fool
Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent
December 28, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.